Translational Pathways for Cardiovascular Devices – Session VI: The Endpoints for Left Ventricular Assist Device Evaluation – Keith Aaronson Practice Quiz
Quiz Summary
0 of 6 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
You have completed the practice quiz, please continue on to the next session.
- 1
- 2
- 3
- 4
- 5
- 6
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 6
1. Question
According to the ENDURANCE trial, the 2 year complication rate of ventricular assist devices is:
CorrectIncorrect -
Question 2 of 6
2. Question
The 2 year rehospitalization rate for ventricular assist devices according to the ENDURANCE trial is 84%
CorrectIncorrect -
Question 3 of 6
3. Question
Reducing ventricular assist device infection reduces thromboembolic events
CorrectIncorrect -
Question 4 of 6
4. Question
The following are clinical endpoints for VAD
CorrectIncorrect -
Question 5 of 6
5. Question
VAD therapy reduces rehospitalization by approximately 50%
CorrectIncorrect -
Question 6 of 6
6. Question
Currently there is no quality of life metric to adequately assess VAD patients
CorrectIncorrect